| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 243.08B | 237.86B | 213.90B | 209.11B | 199.19B | 161.70B |
| Gross Profit | 40.25B | 38.12B | 28.44B | 25.04B | 24.61B | 21.00B |
| EBITDA | 26.88B | 23.59B | 16.46B | 13.97B | 13.38B | 11.04B |
| Net Income | 11.50B | 11.40B | 8.84B | 9.41B | 9.35B | 4.97B |
Balance Sheet | ||||||
| Total Assets | 186.55B | 197.71B | 161.58B | 156.65B | 147.36B | 129.46B |
| Cash, Cash Equivalents and Short-Term Investments | 12.33B | 19.45B | 7.34B | 4.04B | 3.36B | 4.17B |
| Total Debt | 51.18B | 54.73B | 30.28B | 40.95B | 39.17B | 37.69B |
| Total Liabilities | 101.58B | 112.08B | 84.45B | 88.26B | 88.42B | 81.29B |
| Stockholders Equity | 83.31B | 83.66B | 75.91B | 67.50B | 58.27B | 47.57B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.16B | 14.06B | -324.00M | -4.14B | 5.63B |
| Operating Cash Flow | 0.00 | 13.11B | 17.74B | 4.16B | 428.00M | 8.88B |
| Investing Cash Flow | 0.00 | 71.00M | 1.02B | -3.42B | -1.52B | -3.36B |
| Financing Cash Flow | 0.00 | -1.45B | -15.63B | -213.00M | 64.00M | -5.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥411.17B | 14.04 | 18.90% | 1.64% | 7.08% | 65.71% | |
73 Outperform | ¥519.67B | 8.10 | 9.63% | 2.12% | 3.05% | -16.11% | |
72 Outperform | ¥1.15T | 35.76 | 8.39% | 1.49% | -2.18% | 30.16% | |
72 Outperform | ¥7.75T | 26.86 | 32.32% | 0.91% | 27.53% | 137.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥1.63T | 19.95 | 12.05% | 1.50% | 5.44% | -5.19% | |
61 Neutral | ¥2.27T | 7.80 | 10.06% | 1.21% | 10.52% | 60.75% |